Neal Walker
2019
In 2019, Neal Walker earned a total compensation of $3.2M as President and Chief Executive Officer at Aclaris Therapeutics, a 28% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $203,940 |
---|---|
Salary | $499,875 |
Stock Awards | $2,434,518 |
Other | $11,688 |
Total | $3,150,021 |
Walker received $2.4M in stock awards, accounting for 77% of the total pay in 2019.
Walker also received $203.9K in non-equity incentive plan, $499.9K in salary and $11.7K in other compensation.
Rankings
In 2019, Neal Walker's compensation ranked 3,885th out of 13,971 executives tracked by ExecPay. In other words, Walker earned more than 72.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,885 out of 13,971 | 72nd |
Division Manufacturing | 1,401 out of 5,701 | 75th |
Major group Chemicals And Allied Products | 492 out of 2,200 | 78th |
Industry group Drugs | 415 out of 1,886 | 78th |
Industry Pharmaceutical Preparations | 316 out of 1,398 | 77th |
Source: SEC filing on April 23, 2020.
Walker's colleagues
We found three more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2019.